NEW HAVEN, CT
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INSTITUTE FOR NEURODEGENERATIVE DISORDERS, founded in 2001, is a mid-sized nonprofit in the Medical Research sector that reported $22.0M in total revenue in fiscal year 2024. Revenue surged 22% from the prior year, signaling strong growth momentum. Expenses of $18.9M left a modest 14% surplus.
MEDICAL RESEARCH TO LEARN ABOUT CAUSES AND POSSIBLE CURES FOR NEURODEGENERATIVE DISORDERS SUCH AS ALZHEIMER AND PARKINSON DISORDER.
THE INSTITUTE FOR NEURODEGENERATIVE DISORDERS, INC. IS A NON-PROFIT 501(C)(3) RESEARCH INSTITUTE DEDICATED TO THE DEVELOPMENT OF DIAGNOSTIC TOOLS AND IMPROVED TREATMENTS FOR NEUROLOGIC DISORDERS LIKE...
THE INSTITUTE FOR NEURODEGENERATIVE DISORDERS, INC. IS A NON-PROFIT 501(C)(3) RESEARCH INSTITUTE DEDICATED TO THE DEVELOPMENT OF DIAGNOSTIC TOOLS AND IMPROVED TREATMENTS FOR NEUROLOGIC DISORDERS LIKE PARKINSON DISEASE, ALZHEIMER DISEASE AND HUNTINGTON DISEASE. WE WILL ACCOMPLISH OUR MISSION THROUGH CLINICAL RESEARCH.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $21,955,732 | $17,985,784 | +0.2% |
| Expenses | $18,928,370 | $16,134,770 | +0.2% |
| Net Income | $3,027,362 | $1,851,014 | +0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KIMBERLY FABRIZIO | CHIEF OP. OF | 40.00 |
Officer
|
$331,671 | $108,160 | $439,831 |
| KEN MAREK | DISTINGUISHE | 40.00 |
Officer
Director
|
$332,726 | $104,599 | $437,325 |
| DAVID LUNT | CHIEF FIN. O | 40.00 |
Officer
|
$277,324 | $99,775 | $377,099 |
| CRAIG E STANLEY | EMPLOYEE | 40.00 |
Key Emp
|
$283,983 | $43,272 | $327,255 |
| BRIDGET MCMAHON | EMPLOYEE | 40.00 |
Key Emp
|
$248,052 | $75,747 | $323,799 |
| EMILY FLAGG | EMPLOYEE | 40.00 |
Key Emp
|
$223,811 | $26,736 | $250,547 |
| ZEINA SINGH | EMPLOYEE | 40.00 |
Highest
|
$189,675 | $51,599 | $241,274 |
| LYNNE STICKLE | EMPLOYEE | 40.00 |
Highest
|
$149,389 | $66,045 | $215,434 |
| LYNELL LEMON | EMPLOYEE | 40.00 |
Highest
|
$177,310 | $31,325 | $208,635 |
| JOHN-MICHAEL TALARICO | EMPLOYEE | 40.00 |
Highest
|
$175,239 | $30,434 | $205,673 |
| CECILIA F REYES | EMPLOYEE | 40.00 |
Highest
|
$157,086 | $42,412 | $199,498 |
| THOMAS TROPEA | CHIEF MEDICA | 40.00 |
Officer
|
$68,050 | $15,770 | $83,820 |
| HARVEY DANN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| REBECCA EVANS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL FORTE | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DANNA JENNINGS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JACK MARIOTTI | BOARD MEMBER | 20.00 |
Director
|
$0 | $0 | $0 |
| JOHN SEIBYL | CHAIRMAN | 1.00 |
Director
|
$0 | $0 | $0 |
| CHERYL YANOSY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $21,955,732 | $18,928,370 | $14,625,379 | $3,027,362 |
| 2023 | $17,985,784 | $16,134,770 | $9,693,922 | $1,851,014 |
| 2022 | $12,127,200 | $11,240,095 | $6,387,631 | $887,105 |
| 2021 | $8,708,583 | $8,118,394 | $7,010,755 | $590,189 |
| 2020 | $5,678,379 | $5,752,166 | $4,224,515 | $-73,787 |
| 2019 | $6,274,529 | $6,005,297 | $5,169,355 | $269,232 |
| 2018 | $5,370,037 | $4,084,992 | $2,199,960 | $1,285,045 |
Compare INSTITUTE FOR NEURODEGENERATIVE DISORDERS with other nonprofits in Connecticut and across the country.